Indication

Opioid-induced constipation

Opioid-induced constipation is an adverse gastrointestinal disorder characterized by new or worsening constipation symptoms triggered by the initiation, alteration, or dose escalation of opioid analgesic therapy. Read more about Opioid-induced constipation

28 drugs 25 manufacturers

Advertisement

Drugs that treat it

Common Opioid-induced constipation therapies.

Showing 1–9 of 28 drugs

AMITIZA (lubiprostone)

IRRITABLE BOWEL SYNDROME AGENTS·CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
Takeda Pharmaceuticals America
Filter & compare in the drug finder →Opens the drug finder with Opioid-induced constipation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Opioid-induced constipation.

Opioid-induced constipation is an adverse gastrointestinal disorder characterized by new or worsening constipation symptoms triggered by the initiation, alteration, or dose escalation of opioid analgesic therapy.

It primarily affects the enteric nervous system and digestive tract in acute and chronic pain populations, including individuals with cancer-related or noncancer pain.

Pathophysiologically, exogenous opioids bind to peripheral mu-opioid receptors within the bowel wall, resulting in suppressed peristalsis, decreased mucosal and fluid secretion, delayed gastrointestinal transit, and elevated anal sphincter tone.

Clinically, this manifests as reduced stool frequency, hard or lumpy stools, excessive straining, abdominal distension, and a persistent sensation of incomplete rectal evacuation that typically does not resolve with tolerance.

Personalize your experience

Follow Opioid-induced constipation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it